Results 11 to 20 of about 212,620 (328)

Cerebral Small Vessel Disease [PDF]

International Journal of Molecular Sciences, 2020
Cerebral small vessel disease (CSVD) represents a cluster of various vascular disorders with different pathological backgrounds. The advanced vasculature net of cerebral vessels, including small arteries, capillaries, arterioles and venules, is usually ...
J. Litak, M. Mazurek, B. Kulesza, P. Szmygin, Joanna Litak, P. Kamieniak, C. Grochowski   +6 more
semanticscholar   +9 more sources

Prevalence and Consequences of Cerebral Small Vessel Diseases: A Cross-Sectional Study Based on Community People Plotted Against 5-Year Age Strata. [PDF]

Neuropsychiatr Dis Treat, 2022
Ronghua Mu,1,2,* Xiaoyan Qin,2,* Zixuan Guo,1,2,* Zhuoni Meng,1,2 Fuzhen Liu,2 Zeyu Zhuang,1,2 Wei Zheng,1,2 Xin Li,2 Peng Yang,2 Yuling Feng,2 Yanchun Jiang,3 Xiqi Zhu2 1Graduate School of Guilin Medical University, Guilin, 541004, People’s ...
Mu R, Qin X, Guo Z, Meng Z, Liu F, Zhuang Z, Zheng W, Li X, Yang P, Feng Y, Jiang Y, Zhu X.   +11 more
europepmc   +2 more sources

Cerebral small vessel disease: A review.

Advances in Clinical and Experimental Medicine, 2021
Cerebral small vessel disease (CSVD) is the most common, chronic and progressive vascular disease. The changes affect arterioles, capillaries and small veins supplying the white matter and deep structures of the brain.
J. Chojdak-Łukasiewicz, E. Dziadkowiak, A. Zimny, B. Paradowski   +3 more
semanticscholar   +4 more sources

Cerebral Small Vessel Disease and Chronic Kidney Disease [PDF]

Journal of Stroke, 2015
Chronic kidney disease, defined by a decreased glomerular filtration rate or albuminuria, is recognized as a major global health burden, mainly because it is an established risk factor for cardiovascular and cerebrovascular diseases. The magnitude of the
Kazunori Toyoda
doaj   +3 more sources

Cerebral Small Vessel Disease and Alzheimer's Disease: A Review

Frontiers in Neurology, 2020
Alzheimer's disease (AD) is the most common cause of dementia. Despite this, clear pathophysiology for AD has not been confirmed, and effective treatments are still not available.
Hae Won Kim, Jeongho Hong, Jae Cheon Jeon   +2 more
doaj   +2 more sources

Editorial: Cerebral Small Vessel Diseases: From Vessel Alterations to Cortical Parenchymal Injury. [PDF]

Front Neurol, 2020
van Veluw SJ, Jouvent E, Charidimou A.
europepmc   +2 more sources

Blood urea nitrogen to albumin ratio is associated with cerebral small vessel diseases. [PDF]

Sci Rep
Blood urea nitrogen (BUN) to albumin ratio (BAR) is a comprehensive parameter that reflects renal, inflammatory, nutritional, and endothelial functions.
Nam KW, Kwon HM, Jeong HY, Park JH, Min K.   +4 more
europepmc   +2 more sources

Monocyte to high-density lipoprotein cholesterol ratio is associated with cerebral small vessel diseases. [PDF]

BMC Neurol
Background Inflammation is a major pathological mechanism underlying cerebrovascular disease. Recently, a new inflammatory marker based on the ratio between monocyte count and high-density lipoprotein (HDL) cholesterol has been proposed.
Nam KW, Kwon HM, Jeong HY, Park JH, Min K.   +4 more
europepmc   +2 more sources

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial. [PDF]

Lancet Neurol, 2019
Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy.
Al-Shahi Salman R, Minks DP, Mitra D, Rodrigues MA, Bhatnagar P, du Plessis JC, Joshi Y, Dennis MS, Murray GD, Newby DE, Sandercock PAG, Sprigg N, Stephen J, Sudlow CLM, Werring DJ, Whiteley WN, Wardlaw JM, White PM, RESTART Collaboration.   +18 more
europepmc   +7 more sources

Quantitative vascular pathology and phenotyping familial and sporadic cerebral small vessel diseases. [PDF]

Brain Pathol, 2013
Craggs LJ, Hagel C, Kuhlenbaeumer G, Borjesson-Hanson A, Andersen O, Viitanen M, Kalimo H, McLean CA, Slade JY, Hall RA, Oakley AE, Yamamoto Y, Deramecourt V, Kalaria RN.   +13 more
europepmc   +2 more sources